Adult hospital and ventilator-associated pneumonia guidelines: Eminence- rather than evidence-based [3]

American Journal of Respiratory and Critical Care Medicine

Volumn 173, Issue 1, 2006, Pages 131-133

  Silvestri, Luciano ^a   Van Saene, Hendrick K F ^b   De La Cal, Miguel A ^c   Gullo, Antonino ^d  

^a Ospedale Civile di Gorizia   (Italy)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c HOSPITAL UNIVERSITARIO DE GETAFE   (Spain)

^d UNIVERSITY OF TRIESTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIINFECTIVE AGENT; CHLORHEXIDINE; POLYMYXIN; TOBRAMYCIN; VANCOMYCIN;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; HUMAN; INFECTION RATE; INTENSIVE CARE; KLEBSIELLA PNEUMONIAE; LETTER; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORTALITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RESPIRATORY TRACT INFECTION; VANCOMYCIN RESISTANT ENTEROCOCCUS; VENTILATOR ASSOCIATED PNEUMONIA;

EID: 30344467537     PISSN: 1073449X     EISSN: 1073449X     Source Type: Journal    
DOI: 10.1164/ajrccm.173.1.131     Document Type: Letter

References (37)

1. American Thoracic Society; Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and health care-associated pneumonia. Am J Respir Crit Care Med 2005;171:388-416.
2. Johanson WG Jr, Pierce AK, Sanford JP, Thomas GD. Nosocomial respiratory infections with gram-negative bacilli: the significance of colonization of the respiratory tract. Ann Intern Med 1972;77:701-706.
3. DeRiso AJ II, Ladowski JS, Dillon TA, Justice JW, Peterson AC. Chlorhexidine gluconate 0.12% oral rinse reduces the incidence of total nosocomial respiratory infection and nonprophylactic systemic antibiotic use in patients undergoing heart surgery. Chest 1996;109:1556-1561.
4. Macnaughton PD, Bailey J, Donlin N, Branfield P, Williams A, Rowswell H. A randomized controlled trial assessing the efficacy of oral chlorhexidine in ventilated patients. Intensive Care Med 2004;30(Suppl 1):S12.
5. de Jonghe E. Effects of selective decontamination of the digestive tract on mortality and antibiotic resistance in the intensive care unit. Curr Opin Crit Care 2005;11:144-149.
6. Liberati A, D'Amico R, Pifferi S, Torri V, Brazzi L. Antibiotic prophylaxis to reduce respiratory tract infections and mortality in adults receiving intensive care [Cochrane Review]. In: The Cochrane Library, Issue 1. Chichester, UK: John Wiley & Sons; 2004.
7. Brun-Buisson C, Legrand P, Rauss A, Richard C, Montravers F, Besbes M, Meakins JL, Soussy CJ, Lemaire F. Intestinal decontamination for control of nosocomial multi-resistant gram-negative bacilli. Ann Intern Med 1989;110:873-881.
8. Lingnau W, Berger J, Javorsky F, Fille M, Allenberger F, Benzer H. Changing bacterial ecology during a five year period of selective intestinal decontamination. J Hosp Infect 1998;39:195-206.
9. Taylor ME, Oppenheim BA. Selective decontamination of the gastrointestinal tract as an infection control measure. J Hosp Infect 1991;17:271-278.
10. Ferrer M, Torres A, Gonzalez J. Puig de la Bellacasa J, El-Ebiary M. Roca M, Gatell JM, Rodriguez-Roisin R. Utility of selective digestive decontamination in mechanically ventilated patients. Ann Intern Med 1994;120:389-395.
11. Gastinne H, Wolff M, Delatour F, Faurisson F, Chevret S, for the French Study Group on Selective Decontamination of the Digestive Tract. A controlled trial in intensive care units of selective decontamination of the digestive tract with nonabsorbable antibiotics. N Engl J Med 1992;326:594-599.
12. Hammond JMJ, Potgieter PD, Saunders GL, Forder AA. Double-blind study of selective decontamination of the digestive tract in intensive care. Lancet 1992;340:5-9.
13. Lingnau W, Berger J, Javorsky F, Lejeune Ph, Mutz N, Benzer H. Selective intestinal decontamination in multiple trauma patients: prospective, controlled trial. J Trauma 1997;42:687-694.
14. Verwaest Ch, Verhaegen J, Ferdinande P, Schetz M, van den Berge G, Verbist L, Lauwers P. Randomised, controlled trial of selective digestive decontamination in 600 mechanically ventilated patients in a multidisciplinary intensive care unit. Crit Care Med 1997;25:63-71.
15. Wiener J, Itokazu G, Nathan C, Kabins SA, Weinstein RA. A randomized, double-blind, placebo-controlled trial of selective digestive decontamination in a medical-surgical intensive care unit. Clin Infect Dis 1995;20:861-867.
16. de la Cal MA, Cerda E, Garcia-Hierro P, van Saene HKF, Gomez-Santos D, Negro E, Lorente JA. Survival benefit in critically ill burned patients receiving selective decontamination of the digestive tract: a randomised, placebo-controlled, double-blind trial. Ann Surg 2005;241:424-430.
17. Silvestri L, van Saene HKF, Milanese M, Fontana F, Gregori D, Oblach L, Piacente N, Blazic M. Prevention of MRSA pneumonia by oral vancomycin decontamination: a randomised trial. Eur Respir J 2004;23:921-926.
18. Arnow PM, Carandang GR, Zabner R, Irwin ME. Randomised controlled trial of selective bowel decontamination for prevention of infections following liver transplantation. Clin Infect Dis 1996;22:997-1003.
19. Hellinger WC, Yao JD, Alvarez S, Blair JE, Cawley JJ, Paya CV, O'Brien PC, Spivey JR, Dickson RC, Harnois DM, et al. A randomised, prospective, double-blind evaluation of selective bowel decontamination in liver transplantation. Transplantation 2002;73:1904-1909.
20. Bergmans DCJJ, Bonten MJM, Gaillard CA, Paling JC, van der Geest S, van Tiel FH, Beysens AJ, de Leeuw PW, Stobberingh EE. Prevention of ventilator-associated pneumonia by oral decontamination: a prospective, randomized, double-blind, placebo-controlled study. Am J Respir Crit Care Med 2001;164:382-388.
21. Gaussorges Ph, Salord F, Sirodot M, Tigaud S, Cagnin S, Gerard M, Robert D. Nosocomial bacteremia in patients under mechanical ventilation and receiving beta-inotropic drugs: efficacy of digestive decontamination. Réanimation Soins Intensifs et Medicine Urgences 1991;7:169-174.
22. Korinek AM, Laisne MJ, Nicolas MH, Raskine L, Deroin V, Sanson-Lepors MJ. Selective decontamination of the digestive tract in neurosurgical intensive care unit patients: a double-blind, randomized, placebo-controlled study. Crit Care Med 1993;21:1466-1473.
23. Krueger WA, Lenhart F-P, Neeser G, Ruckdeschel G, Schreckhase H, Eissner H-J, Forst H, Eckart J, Peter K, Unertl KE. Influence of combined intravenous and topical antibiotic prophylaxis on the incidence of infections, organ dysfunctions, and mortality in critically ill surgical patients. A prospective, stratified, randomized, double-blind, placebo-controlled clinical trial. Am J Respir Crit Care Med 2002;166:1029-1037.
24. Pugin J, Auckenthaler R, Lew DP, Suter PM. Oropharyngeal decontamination decreases incidence of ventilator-associated pneumonia. A randomized, placebo-controlled, double-blind clinical trial. JAMA 1991;265:2704-2710.
25. Schardey HM, Joosten U, Finke U, Staubach KH, Schauer R, Heiss A, Kooistra A, Rau HG, Nibler R, Ludeling S, et al. The prevention of anastomotic leakage after total gastrectomy with local decontamination: a prospective, randomized, double-blind, placebo-controlled multicenter trial. Ann Surg 1997;225:172-180.
26. Sanchez M, Mir N, Canton R, Lugue R, Lopez B, Baguero F. The effect of topical vancomycin on acquisition, carriage and infection with methicillin-resistant Staphylococcus aureus in critically ill patients: a double-blind, randomized, placebo-controlled study. 37th ICAAC; 1997; Toronto, Canada. Abstract J-119, p. 310.
27. Stiefel U, Pultz NJ, Harmoinen J, Koski P, Lindevall K, Helfand MS, Donskey CJ. Oral administration of β-lactamase preserves colonisation resistance of piperacillin-treated mice. J Infect Dis 2003;188:1605-1609.
28. Stiefel U, Paterson DL, Pultz NJ, Gordon SM, Aron DC, Donskey CJ. Effect of the increasing use of piperacillin/tazobactam on the incidence of vancomycin-resistant-enterococci in four academic medical centers. Infect Control Hosp Epidemiol 2004;25:380-383.
29. Salgado CD, Giannetta ET, Farr BM. Failure to develop vancomycin-resistant Enterococcus with oral vancomycin treatment of Clostridium difficile. Infect Control Hosp Epidemiol 2004;25:413-417.
30. Hammond JMJ, Potgieter PD. Long-term effects of selective decontamination on antimicrobial resistance. Crit Care Med 1995;23:637-645.
31. Stoutenbeek CP, van Saene HKF, Zandstra DF. The effect of oral non-absorbable antibiotics on the emergence of resistant bacteria in patients in an intensive care unit. J Antimicrob Chemother 1987;19:513-520.
32. Lingnau W, Berger J, Javorsky F, Fille M, Allenberger F, Benzer H. Changing bacterial ecology during a five year period of selective intestinal decontamination. J Hosp Infect 1998;39:195-206.
33. Sarginson RE, Taylor N, Reilly N, Baines PB, van Saene HKF. Infection in prolonged pediatric critical illness. A prospective four-year study based on knowledge of the carrier state. Crit Care Med 2004;32:839-847.
34. Leone M, Albanese J, Antonini F, Nguyen-Michel A, Martin C. Long-term (6 year) effect of selective digestive decontamination on antimicrobial resistance in intensive care, multitrauma patients. Crit Care Med 2003;31:2090-2095.
35. de la Cal MA, Cerda E, van Saene HKF, Garcia-Hierro P, Negro E, Parra ML, Arias S, Ballestreros D. Effectiveness and safety of enteral vancomycin to control endemicity of methicillin-resistant Staphylococcus aureus in a medical/surgical intensive care unit. J Hosp Infect 2004;56:175-183.
36. Tetteroo GWM, Wagenvoort JHT, Bruining HA. Bacteriology of selective decontamination: efficacy and rebound colonization. J Antimicrob Chemother 1994;34:139-148.
37. Abella A, de la Cal MA, Cerda E, Lopez L, Alia I, Garcia-Hierro P, Aranguren A. Control of MRSA endemicity with enteral vancomycin in a burn intensive care unit. Intensive Care Med 2004;30(Suppl 1):S145.